Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers

Turkish Journal of Gastroenterology

Volumn 14, Issue 3, 2003, Pages 157-163

  Yalçin, Kendal ^a,b   Deǧertekin, Halil ^a   Alp, M Nail ^a   Tekeş, Selahattin ^a   Satici, Ömer ^a   Budak, Turgay ^a  

^a DICLE UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

ALT; Anti HBe; Chronic hepatitis B virus infection; HAI; HBeAg; HBV DNA; Hepatitis B virus

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; DISEASE COURSE; DISEASE MARKER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; TURKEY (REPUBLIC); VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; BIOLOGICAL MARKERS; CARRIER STATE; DNA, VIRAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX;

EID: 17444442561     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
2. Di Marco V, Lo Iacono O, Camma C, et al. The long-term course of chronic hepatitis B. Hepatology 1999; 30: 257-64.
3. McMahon BJ, Holck P, Bulkow L, Snowball MM. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001; 135: 759-68.
4. Chu CM, Karayiannis P, Fowler MJ, et al. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 1985; 5: 431-34.
5. Alberti A, Pontisso P, Fattovich G, et al. Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. J Infect Dis 1986; 154: 562-69.
6. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. Hepatology 1983; 3: 656-62.
7. Bonino F, Hoyer B, Nelson J, et al. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology 1981; 1: 386-91.
8. Jardi R, Buti M, Rodriguez-Frias F, et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996; 24: 680-85.
9. Lok AS, Heathcete J, Hoofflagle J. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 2001; 120: 1828-53.
10. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptematic asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-35.
11. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific, 1994.
12. Deǧertekin H, Tuzcu A, Yalçin K. Horizontal transmission of HBV infection among students in Turkey. Public Health 2000; 114: 411-12.
13. Deǧertekin H, Kastellioǧlu F. The prevalence of HBsAg in healthy people and several liver diseases in Turkey. Asian Med J 1986; 29: 125-27.
14. Yalčin K, Deǧertekin H, Alp MN, et al. Serum HBV DNA levels in chronic hepatitis B patients in south-eastern Turkey. Turk J Gastroenterol 2000; 1: S90 (Abstract).
15. Berris B, Sampliner RE, Sooknanan R, Feinman SV. Hepatitis B virus DNA in asymptomatic HBsAg carriers: comparison with HBeAg/anti-HBe status. J Med Virol 1987; 23: 233-39.
16. Fujiwara K, Yokosuka O, Ehata T, et al. The two different states of hepatitis B virus DNA in asymptomatic carriers: HB-e-antigen positive versus anti-HBe positive asymptomatic carriers. Dig Dis Sci 1998; 43: 368-76.
17. Davis GL, Hoofnagle J. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. Ann Intern Med 1985; 102: 762-65.
18. Burrell CJ, Gowans EJ, Rowland R, et al. Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization. Hepatology 1984; 4: 20-24.
19. Suzuki K, Uchida T, Shikata T. Histopathological analysis of chronic hepatitis B virus (HBV) infection in relation to HBV replication. Liver 1987; 7: 260-70.
20. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000; 7: 258-67.
21. Chan HL, Tsang SW, Liew CT, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2002; 97: 406-12.
22. Zarski JP, Marcellin P, Cohard M, et al. Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group. J Hepatol 1994; 20: 636-40.
23. Lieberman HM, LaBrecque DR, Kew MC, et al. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridisation test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology 1983; 3: 285-91.
24. Stroffolini T, Sagnelli E, Rapicetta M, et al. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology. Hepatogastroenterology 1992; 39: 62-65.
25. Amarapurkar DN, Baijal R, Kulshrestha PP, et al. Profile of hepatitis B e antigen-negative chronic hepatitis B. Indian J Gastroenterol 2002; 21: 99-101.
26. Rapicetta M, di Nardo V, Rozera C, et al. HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy. Epidemiol Infect 1990; 104: 511-17.
27. Sakugawa H, Nakasone H, Nakayoshi T, et al. Correlation between serum transaminase activity and virus load among patients with chronic liver disease type B. Hepatol Res 2001; 21: 159-68.
28. Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B. core antigen serum levels predictors of histological grading in chronic hepatitis B Liver 1997; 17: 83-87.
29. Borg F, ten Kate FJW, Cuypers HTM, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 1998; 351; 1914-18.
30. Ljunggren KK, Nordenfelt E, Kidd A. Correlation of HBeAg/Anti-HBe, ALT levels, and HBV DNA PCR result in HBsAg-positive patients. J Med Virol 1993; 39: 297-302.
31. Chun YK, Kim JY, Woo HJ, et al. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology 2000; 32: 1154-62.